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First year of 24/7 Acute Stroke Unit. Part 1: eligibility and utilisation of intravenous  
thrombolysis
MWM Kwan, SFK Hon, RSK Chang, SYY Pang, JCY Lee, C Chang, SL Ho, RTF Cheung, W Mak
Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
introduction: Intravenous recombinant tissue plasminogen activator (IV-rtPA) is the standard therapy for 
acute ischaemic stroke. Because of its narrow therapeutic time window, eligibility and utilisation rates of this 
treatment remained low. Our IV-rtPA programme was enhanced to a 24/7 protocol since September 2011.
Methods: Records of patients admitted to Acute Stroke Unit (ASU) over the first 12 months were reviewed for 
the utilisation pattern of IV-rtPA.
Results: A total of 447 patients were admitted to the ASU during the study period, in whom 384 (86%) were 
diagnosed to have stroke or transient ischaemic attack (TIA) upon discharge. Of these, 188 (49%) presented 
within 3 hours of symptom onset, in whom 122, 34, or 32 (65%, 18%, or 17%) had ischaemic stroke, TIA or 
intracranial haemorrhage, respectively. For the 122 ischaemic stroke patients, assessment for the suitability of 
IV-rtPA could be completed in 113 (93%) of them before the 3 hours therapeutic time-window expired. Sixty-
six (58%) of them were considered not suitable candidates for intravenous thrombolysis because of presence 
of contra-indications. In the remaining 47 patients, IV-rtPA was given in 44 cases (94%, one additional case was 
treated with an extended therapeutic time-window of 4.5 hours).
Conclusion: The 24/7 ASU protocol enabled the timely assessment of acute stroke patients, with 93% having 
their essential workup completed within 3 hours of stroke onset, and a 94% utilisation rate of IV-rtPA in those 
who were eligible for treatment. With this model, the routine administration of thrombolytic therapy for acute 
ischaemic stroke can be facilitated.
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Variants, clinical characteristics and prognostic factors of Guillain-Barré syndrome in Chinese
HM Kwok, HL Tsui, WY Wong, YK Wong, RSK Chang, W Mak, SFK Hon, RTF Cheung, SL Ho, KH Chan, KK Lau
Division of Neurology, Department of Medicine, The University of Hong Kong, Hong Kong
introduction: The variants, clinical characteristics, and prognostic factors of Guillain-Barré syndrome (GBS) in 
Hong Kong Chinese has not been widely studied previously. 
Methods: We performed a retrospective review of adults with GBS admitted to Queen Mary Hospital, Hong 
Kong during the period 1997-2011. 
Results: Mean age of the patients was 57±17 years and the mean length of hospital stay was 36±69 days. Male-to-
female ratio was 1.5:1. Of the 63 patients with GBS during this period, 3 (4.8%) patients had acute motor axonal 
neuropathy, 11 (17.5%) with Miller Fisher syndrome and 50 (77.8%) had acute inflammatory demyelinating 
polyneuropathy together with other unspecified subtypes. Of the patients, 31 (49.2%) had preceding upper 
respiratory tract illness, 3 (4.76%) had preceding gastrointestinal illness, whilst 5 (7.94%) received vaccination 
during the 6 weeks preceding onset of neurological symptoms; 14 (22.2%) patients were admitted to 
Intensive Care Unit and 8 patients (12.7%) required mechanical ventilation; 12 (19.0%) patients were treated 
conservatively, 25 (39.7%) received intravenous immunoglobulin only, 19 (30.2%) received plasmapheresis 
only and 7 (11.0%) received both intravenous immunoglobulin and plasmapheresis. Of the patients, 36.1% of 
patients were associated with poor functional recovery (requiring walking with aid at 6 months after admission). 
Two (3.18%) patients died during hospital stay (one due to nosocomial pneumonia and the other due to cardiac 
arrhythmia). Multivariate analysis revealed that necessity of mechanical ventilation during hospitalisation 
(odds ratio=43.3; 95% confidence interval: 1.2-1539.4; P=0.039) was an independent predictor of poor functional 
recovery at 6 months after admission. Receiver operating characteristics curve analysis also showed that an 
Erasmus GBS Outcome Score of >4 was associated with good functional recovery with a c statistic of 0.87 
(P<0.0001).
Conclusions: The proportion of patients with Miller Fisher syndrome is significantly greater in the Chinese 
population compared to the West. Necessity of mechanical ventilation during hospitalisation is an independent 
predictor of poor functional recovery 6 months after admission and the Erasmus GBS Outcome Score is a 
useful score in predicting functional recovery. 
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